Chamber and committees

The following primary care projects were allocated capital funding by the Scottish Government in the period 2019-20 to 2023-24:

The Scottish Government will be investing in the North East Glasgow Health and Care Centre over the next two financial years.

A number of other proposals are currently being reviewed, however, as a result of very high levels of inflation in the construction industry and a lower than expected capital grant from the UK Government, there is no ability to expand the health capital investment programme at this point. Therefore, any projects not identified as priorities within the Infrastructure Investment Plan will not be able to be funded until likely 2026.

The Scottish Government is investing £34.2 million in the North East Glasgow Health and Care Centre in 2023-24, which is part of £66.4 million investment in the centre that covers the period 2019-20 to 2024-25.

A further £6.0 million is being invested across various other primary care capital projects in NHS Highland in 2023-24.

All of the above projects are progressing on time and within budget.

This information is not held centrally by the Scottish Government.

At this stage it is not possible to estimate the cost of the removal or remedial action required for reinforced autoclaved aerated concrete within the NHS.

The Scottish Government is not currently involved in any modelling work relating specifically to BA.2.86 (known in the media as the Pirola variant), but we continue to work closely with Public Health Scotland and other partners to monitor, assess and be ready to respond to any new outbreaks of COVID-19.

Public Health Scotland (PHS) include analysis on COVID-19 variants as part of their “ National respiratory infection and COVID-19 statistics ”. The report published on 14 September 2023 included the latest COVID-19 cases, wastewater levels and hospitalisations, as well as analysis on BA.2.86. Additionally, PHS currently publish a weekly update providing the latest information on BA.2.86 ( SARS-CoV-2 BA.2.86 variant in Scotland - weekly update - COVID-19 data and intelligence - COVID-19 - Infectious diseases - Health protection - Our areas of work - Public Health Scotland) .

The risks continue to be low but in response to the identification of changes in variant BA. 2.86, we have taken the precautionary measure of bringing forward the planned vaccination of those at highest risk.

The last procurement for Covid Lateral Flow Device tests in March 2022 was aligned to the Test and Protect Transition Plan, taking account of the potential need to continue a range of testing pathways, and for contingency purposes if required

Approximately 15 million LFD tests belonging to Scotland are in UK Health Security Agency and partner warehouses (12.1m), in care homes for contingency purposes and to support clinical care (1.6m), and NHS National Services Scotland and partner warehouses (1.3m).

I refer the member to the answer to question S6W-19366 on 21 July 2023 in relation to the desktop review and a full list of the 254 properties identified as having two or more characteristics consistent with the presence of RAAC was placed in the Scottish Parliament Information Centre (Bib. Number 64387). NHS Scotland Assure also published the information on their website on 15 September. An update on progress with the national survey programme, including the list of NHS buildings where RAAC is identified, will also be published by NHS Scotland Assure and each local NHS Board.

All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Since July 2020 and until 5 February 2023, Antimicrobial Resistance & Healthcare Associated Infection (ARHAI) Scotland (within NSS) published, weekly validated statistics on the number of hospital-onset COVID-19 infections in Scotland via the Public Health Scotland (PHS) website.

The following table provides the number of cases from the 1 January 2023, until the final publication of statistics on 5 February 2023.

Targeted testing is in place to support clinical decision making and surveillance. We are working closely with Public Health Scotland, our clinical advisors and the other UK nations to routinely review our position and the clinical advice on COVID-19 in light of new variants. Evidence to date does not support a return to widespread community testing however we will continue to monitor the situation closely.